Discerning duplicate drug therapy is not the patient’s job

Patients don't want to understand cross-benefit coordination of therapy. They're trying to get well.

August 31, 2020

Related research

Prime analysis

March 22, 2022

Preparing clients for gene therapy sticker shock

When Prime helps health plan clients get ready for cost increases from a…

Prime analysis

March 17, 2022

Unexpected impacts of COVID-19 go deep in health care, affecting the progress of gene therapy

The impact of COVID-19 on our country has been deep and profound. In…

Prime analysis

February 24, 2022

Strategy for treating osteoporosis at high risk for fracture using MedDrive™

About 10 million Americans have osteoporosis, a disease of the bone that makes…